SPCC191.03c Antibody

What is SPCC191.03c and why is it studied in fission yeast research?

SPCC191.03c is a protein encoded in the genome of Schizosaccharomyces pombe (fission yeast), identified by the UniProt accession number Q9Y7P7. Researchers study this protein primarily in chromatin-related investigations, as it represents one of the numerous chromatin-bound proteins in S. pombe that contribute to genome regulation. Understanding its function provides insights into fundamental eukaryotic cellular processes, as S. pombe serves as an excellent model organism with many conserved pathways relevant to higher eukaryotes. The relatively small genome and genetic tractability of fission yeast make it particularly valuable for studying chromatin dynamics and gene regulation mechanisms that may be applicable across species .

What are the key specifications of commercially available SPCC191.03c antibodies?

The SPCC191.03c antibody (product code CSB-PA896956XA01SXV) is typically available as a research-grade reagent specifically designed for detecting the target protein in Schizosaccharomyces pombe (strain 972 / ATCC 24843). These antibodies are generally supplied in two volume options (2ml/0.1ml) and are produced under standardized conditions to ensure batch-to-batch consistency. The antibody recognizes epitopes specific to the SPCC191.03c protein and can be used in various experimental applications including western blotting, immunoprecipitation, and potentially chromatin immunoprecipitation (ChIP) assays, though specific application validation should be verified with the supplier .

How does SPCC191.03c antibody differ from other S. pombe protein antibodies?

The SPCC191.03c antibody differs from other S. pombe protein antibodies in its target epitope specificity, optimal working conditions, and validated applications. While methodologically similar to antibodies targeting other yeast proteins like SPBC1703.03c (Q9P7W7) or pir2 (O94326), each antibody has unique characteristics determined by the properties of its target protein. Researchers should note that optimal conditions for SPCC191.03c antibody use (including dilution ratios, incubation times, and buffer compositions) may differ significantly from those established for other S. pombe protein antibodies. Cross-reactivity profiles will also vary, requiring careful experimental design when performing multiplex detection assays .

What is the optimal protocol for using SPCC191.03c antibody in chromatin immunoprecipitation (ChIP) experiments?

For optimal SPCC191.03c antibody performance in ChIP experiments, researchers should follow this refined protocol:

• Culture S. pombe cells to mid-log phase (OD600 ~0.5-0.8) in appropriate media

• Crosslink proteins to DNA using 1% formaldehyde for 15 minutes at room temperature

• Quench with 125mM glycine for 5 minutes

• Harvest cells and lyse using glass bead disruption in lysis buffer (50mM HEPES-KOH pH 7.5, 140mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, protease inhibitors)

• Sonicate chromatin to 200-500bp fragments

• Pre-clear lysate with protein A/G beads for 1 hour at 4°C

• Incubate pre-cleared lysate with SPCC191.03c antibody (2-5μg) overnight at 4°C

• Add protein A/G beads and incubate for 2-3 hours at 4°C

• Wash beads sequentially with lysis buffer, high-salt buffer, LiCl buffer, and TE buffer

• Elute DNA-protein complexes and reverse crosslinks at 65°C overnight

• Treat with RNase A and Proteinase K

• Purify DNA using phenol-chloroform extraction or commercial kits

This protocol borrows from ChIP-on-chip experimental design principles to ensure optimal chromatin capture for subsequent analysis .

How should researchers validate the specificity of SPCC191.03c antibody for their applications?

Validating SPCC191.03c antibody specificity requires a multi-faceted approach:

• Genetic controls: Compare wild-type S. pombe strains with SPCC191.03c deletion mutants or epitope-tagged strains. The antibody should show specific signal in wild-type samples and either no signal (deletion) or altered mobility (tagged) in the modified strains.

• Peptide competition assay: Pre-incubate the antibody with excess synthetic peptide corresponding to the immunogen. This should abolish specific binding in subsequent assays.

• Western blot analysis: Verify single-band detection at the expected molecular weight (~predicted from sequence analysis), with minimal non-specific bands.

• Immunofluorescence correlation: If applicable, compare localization patterns observed with the antibody to GFP/epitope-tagged versions of SPCC191.03c.

• Mass spectrometry validation: Perform immunoprecipitation followed by mass spectrometry to confirm that SPCC191.03c is the primary protein captured.

Proper validation ensures experimental reproducibility and prevents misinterpretation of results due to antibody cross-reactivity .

What are the recommended dilutions and incubation conditions for different applications of SPCC191.03c antibody?

Note: These recommendations serve as starting points; optimization may be necessary for specific experimental conditions. Always perform antibody titration experiments to determine optimal working dilutions for your specific application .

How can researchers optimize SPCC191.03c antibody for quantitative chromatin proteomics studies?

Optimizing SPCC191.03c antibody for quantitative chromatin proteomics requires several critical considerations:

First, implement a rigorous antibody validation workflow including Western blot analysis, immunoprecipitation efficiency assessment, and epitope accessibility verification under different chromatin fixation conditions. For quantitative studies, direct comparison with a tagged version of SPCC191.03c is essential to establish antibody capture efficiency.

Second, incorporate SILAC (Stable Isotope Labeling with Amino acids in Cell culture) or TMT (Tandem Mass Tag) labeling strategies to enable precise relative quantification. For SILAC, culture S. pombe cells in media containing either normal ("light") or heavy isotope-labeled amino acids for at least 8 cell divisions to ensure >95% incorporation.

Third, optimize chromatin fractionation protocols specifically for SPCC191.03c detection. This typically involves sequential extraction with increasingly stringent buffers, followed by immunoprecipitation from the appropriate fraction where SPCC191.03c is enriched.

Finally, implement appropriate normalization strategies during data analysis, using internal reference proteins known to have stable chromatin association across experimental conditions. This approach, as demonstrated in quantitative proteomic studies of chromatin-bound proteins in S. pombe, significantly improves measurement precision for dynamic protein interactions .

What are the proven strategies for resolving non-specific binding issues when using SPCC191.03c antibody?

When encountering non-specific binding with SPCC191.03c antibody, implement these evidence-based troubleshooting strategies:

• Buffer optimization: Adjust salt concentration (try 150-500mM NaCl) and detergent composition (compare Triton X-100, NP-40, and CHAPS at 0.1-1%). Systematic buffer optimization can dramatically reduce background while preserving specific signals.

• Blocking enhancements: Test alternative blocking agents beyond standard BSA/milk, including specific combinations of fish gelatin (1-3%), casein (0.5-2%), and commercially available blocking solutions designed for yeast applications.

• Pre-adsorption protocol: Incubate the diluted antibody with an acetone powder preparation from SPCC191.03c knockout yeast strains to remove antibodies binding to conserved epitopes or common contaminants.

• Epitope competition: Implement a dual-approach strategy using both the immunizing peptide and an unrelated control peptide to differentiate between specific competition and non-specific interference effects.

• Cross-linking optimization: For ChIP applications, perform a formaldehyde concentration gradient (0.5-3%) and time course (5-30 minutes) to identify conditions that maximize specific SPCC191.03c capture while minimizing background.

• Two-dimensional purification: For particularly challenging applications, implement sequential immunoprecipitation with SPCC191.03c antibody followed by a second purification step based on another property of the target complex.

These approaches systematically eliminate sources of non-specific binding through evidence-based optimization rather than trial-and-error testing .

How can SPCC191.03c antibody be integrated into multi-omics studies of fission yeast chromatin?

Integration of SPCC191.03c antibody into multi-omics studies requires careful experimental design across multiple platforms:

For ChIP-seq applications, calibrate SPCC191.03c antibody performance using spike-in controls (such as S. cerevisiae chromatin) to enable normalization across samples and experimental batches. Develop a matched ChIP-seq and ChIP-mass spectrometry workflow that allows direct correlation between SPCC191.03c genomic binding sites and its protein interaction partners at specific loci.

For integration with transcriptomics, perform parallel RNA-seq and SPCC191.03c ChIP-seq under identical experimental conditions, followed by computational integration using tools specifically designed for multi-omics data correlation. This approach can identify direct transcriptional targets versus indirect effects.

For chromatin accessibility studies, complement SPCC191.03c ChIP-seq with ATAC-seq or DNase-seq, then implement bioinformatic workflows to identify relationships between SPCC191.03c binding, chromatin accessibility changes, and transcriptional outcomes.

Establish a unified experimental timeline where samples for different omics approaches are collected from the same cell populations at matched timepoints, minimizing variation from biological replication. Finally, implement advanced computational integration using dimensionality reduction techniques like MOFA (Multi-Omics Factor Analysis) or DIABLO (Data Integration Analysis for Biomarker discovery using Latent variable approaches for Omics) to identify coordinated patterns across data types .

What statistical approaches are recommended for analyzing SPCC191.03c ChIP-seq data?

For robust statistical analysis of SPCC191.03c ChIP-seq data, researchers should implement this comprehensive workflow:

First, perform quality control using FastQC followed by read alignment with Bowtie2 specifically optimized for the S. pombe genome. For peak calling, employ MACS2 with parameters optimized for narrow binding sites (typical of sequence-specific factors) or broader domains (for certain chromatin-associated proteins), depending on the expected binding pattern of SPCC191.03c.

For differential binding analysis between conditions, implement either DESeq2 or edgeR with appropriate dispersion estimation, utilizing a paired design when comparing treatments within the same strain. Control for batch effects using either ComBat or RUVSeq before differential analysis if experiments span multiple sequencing runs.

Critically, validate biological significance by integrating random permutation tests to establish empirical false discovery rates rather than relying solely on p-value adjustments. For peak annotation and functional enrichment, use region-gene association strategies that account for the compact nature of the S. pombe genome.

Finally, implement reproducibility metrics based on the Irreproducible Discovery Rate (IDR) framework when analyzing biological replicates, which provides more stringent quality control than simple overlap measurements. This comprehensive statistical approach delivers robust findings while controlling for the specific characteristics of ChIP-seq experiments in the S. pombe model system .

How should researchers interpret conflicting results between SPCC191.03c antibody-based assays and tagged protein studies?

When facing discrepancies between SPCC191.03c antibody results and tagged protein approaches, implement this systematic reconciliation framework:

Begin by evaluating fundamental technical differences - antibody-based detection recognizes the native protein in its endogenous context, while tagging introduces exogenous elements that may alter protein behavior. Document specific parameters including: epitope availability under experimental conditions, tag interference with protein folding or interactions, expression level differences between endogenous and tagged proteins, and potential clonal selection issues in tagged strains.

Next, perform targeted validation experiments to pinpoint discrepancy sources. These should include:

• Western blot comparison of native versus tagged protein expression levels and molecular weights

• Reciprocal immunoprecipitation followed by mass spectrometry to compare interaction partners

• Functional complementation assays to assess biological activity of tagged constructs

• ChIP-qPCR at selected genomic loci to compare binding patterns directly

If discrepancies persist, implement controlled cellular fractionation to determine if differences reflect altered subcellular distribution rather than absolute differences in detection. Finally, integrate data from orthogonal approaches like RNA-seq following SPCC191.03c depletion or knockout to establish functional ground truth based on downstream effects rather than direct protein detection alone.

This comprehensive approach transforms apparent contradictions into deeper biological insights about SPCC191.03c function and regulation .

What are the best approaches for integrating SPCC191.03c binding data with other chromatin-associated proteins in fission yeast?

For optimal integration of SPCC191.03c binding data with other chromatin factors, implement this advanced analytical framework:

First, generate standardized occupancy profiles by normalizing all datasets to input controls and applying consistent peak calling parameters across factors. Convert binding sites to quantitative occupancy scores using signal intensity measurements within unified genomic intervals (typically 50-100bp bins across the genome).

Next, implement machine learning approaches for pattern discovery: apply non-negative matrix factorization (NMF) to identify combinatorial binding modules, and self-organizing maps (SOMs) to visualize complex relationships between multiple factors. These approaches reveal emergent patterns not apparent from pairwise comparisons.

For direct functional associations, perform quantitative co-occupancy analysis using the genome-wide Spearman correlation of binding signals between SPCC191.03c and other factors, followed by hierarchical clustering to identify functionally related groups. Extend this approach to capture spatial relationships by analyzing binding patterns within defined genomic windows (±2kb around features of interest) using cross-correlation functions.

Finally, integrate binding data with functional genomic elements using region set enrichment analysis (RSEA) against annotated features including promoters, gene bodies, and specialized chromatin structures like replication origins and centromeric regions. This multi-dimensional approach reveals both global patterns and locus-specific behaviors of SPCC191.03c in the context of the broader chromatin landscape .

How might single-cell approaches enhance our understanding of SPCC191.03c function in heterogeneous yeast populations?

Single-cell approaches offer transformative potential for understanding SPCC191.03c's role in cellular heterogeneity, despite technical challenges in yeast. Researchers should consider three emerging methodologies:

First, implement CUT&Tag-seq adapted for single S. pombe cells, which allows direct antibody-based tagging of SPCC191.03c on chromatin followed by high-throughput sequencing. This approach requires significant optimization for cell wall digestion and nucleus isolation, but enables direct assessment of cell-to-cell variation in SPCC191.03c genomic localization without population averaging effects.

Second, develop single-cell immunofluorescence quantification workflows using the SPCC191.03c antibody combined with automated high-content imaging. This permits correlation between SPCC191.03c levels/localization and cell cycle stage, cell size, or other morphological features across thousands of individual cells.

Third, integrate these approaches with single-cell transcriptomics by implementing multi-modal protocols like CITE-seq adapted for yeast, where SPCC191.03c antibody conjugated to oligonucleotide barcodes enables simultaneous quantification of protein levels and transcriptional profiles in the same cells.

These approaches will reveal whether SPCC191.03c exhibits uniform behavior across all cells or functions differently in subpopulations, potentially explaining phenotypic variation observed in genetically identical yeast populations .

What are the emerging applications of SPCC191.03c antibody in studying chromatin dynamics during environmental stress responses?

SPCC191.03c antibody offers unique capabilities for investigating stress-induced chromatin dynamics through several innovative applications:

Develop time-resolved ChIP-seq protocols using the SPCC191.03c antibody to capture transient binding events during acute stress responses. This approach requires rapid fixation methods (1-5 minutes) and precise time-course sampling to capture the earliest chromatin reorganization events before secondary responses emerge.

Implement orthogonal genome-wide mapping using CUT&RUN or CUT&Tag with SPCC191.03c antibody, which offer improved signal-to-noise ratios and require fewer cells than traditional ChIP-seq. This enables studies of chromatin dynamics under multiple stress conditions (oxidative, thermal, osmotic, nutrient deprivation) with limited material.

Combine SPCC191.03c antibody-based chromatin mapping with nascent transcription assays like NET-seq or TT-seq to directly correlate binding dynamics with transcriptional outcomes during stress adaptation. This multi-omic approach reveals both temporal relationships and mechanistic connections between chromatin remodeling and gene expression responses.

Finally, explore chromatin compartmentalization changes using microscopy-based approaches with the SPCC191.03c antibody coupled with domain-specific chromatin markers. This reveals how nuclear architecture reorganization during stress might influence SPCC191.03c function and localization, potentially identifying novel regulatory mechanisms not apparent from sequence-based approaches alone .